Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-01-08
1981-11-24
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112B, 424 12, 424 88, 544271, 435 7, G01N 3358, G01N 3360, C07G 700, C07D47300
Patent
active
043024386
ABSTRACT:
By injecting a host animal with a member of a particular group of antigens [a theophylline-(7)-alkanecarboxylic acid covalently bonded to an immunogenic carrier (IGC) via the carboxyl group], antibodies, advantageously employed in determining small amounts of theophylline in biological liquids by immunoassay methods, are obtained.
REFERENCES:
patent: 4156081 (1979-05-01), Singh et al.
Koup et al., Chem. Abstracts, vol. 89, 1978, abstract #99518x.
Nishikawa et al., Chem. Abstracts, vol. 90, 1979, Abstract #51014y.
ByK Gulden Lomberg Chemische Fabrik GmbH
Nucker Christine M.
LandOfFree
Antigen, antiserum and immunoassay for theophylline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigen, antiserum and immunoassay for theophylline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigen, antiserum and immunoassay for theophylline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2174672